117 related articles for article (PubMed ID: 29415767)
1. Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation.
Yuan X; Lin H; Li B; He K; Fan H
Vet Res; 2018 Feb; 49(1):14. PubMed ID: 29415767
[TBL] [Abstract][Full Text] [Related]
2. Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2.
Lin HX; Ma Z; Fan HJ; Lu CP
Vaccine; 2012 Sep; 30(44):6307-13. PubMed ID: 22884664
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and immunogenicity of recombinant swinepox virus expressing the A epitope of the TGEV S protein.
Yuan X; Lin H; Fan H
Vaccine; 2015 Jul; 33(32):3900-6. PubMed ID: 26116254
[TBL] [Abstract][Full Text] [Related]
4. Construction and Immunogenicity of Recombinant Swinepox Virus Expressing Outer Membrane Protein L of Salmonella.
Fang Y; Lin H; Ma Z; Fan H
J Microbiol Biotechnol; 2016 Jul; 26(7):1173-81. PubMed ID: 27012234
[TBL] [Abstract][Full Text] [Related]
5. Recombinant swinepox virus expressing beta-galactosidase: investigation of viral host range and gene expression levels in cell culture.
Bárcena J; Blasco R
Virology; 1998 Apr; 243(2):396-405. PubMed ID: 9568038
[TBL] [Abstract][Full Text] [Related]
6. Replication and expression of a swinepox virus vector delivering feline leukemia virus Gag and Env to cell lines of swine and feline origin.
Winslow BJ; Cochran MD; Holzenburg A; Sun J; Junker DE; Collisson EW
Virus Res; 2003 Dec; 98(1):1-15. PubMed ID: 14609625
[TBL] [Abstract][Full Text] [Related]
7. First insights into the protective effects of a recombinant swinepox virus expressing truncated MRP of Streptococcus suis type 2 in mice.
Huang D; Zhu H; Lin H; Xu J; Lu C
Berl Munch Tierarztl Wochenschr; 2012; 125(3-4):144-52. PubMed ID: 22515033
[TBL] [Abstract][Full Text] [Related]
8. Swinepox virus as a vaccine vector for swine pathogens.
Tripathy DN
Adv Vet Med; 1999; 41():463-80. PubMed ID: 9890036
[TBL] [Abstract][Full Text] [Related]
9. The recombinant swinepox virus expressing sseB could provide piglets with strong protection against Salmonella typhimurium challenge.
Ji L; Lin X; Yuan K; Li Y; Leghari A; Yuan B; Lin H
Microb Pathog; 2022 Nov; 172():105801. PubMed ID: 36170951
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Swinepox Virus for Veterinary Vaccine Development.
Fan HJ; Lin HX
Methods Mol Biol; 2016; 1349():163-75. PubMed ID: 26458836
[TBL] [Abstract][Full Text] [Related]
11. Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.
Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
Virus Res; 2012 Aug; 167(2):188-95. PubMed ID: 22584406
[TBL] [Abstract][Full Text] [Related]
12. Construction of recombinant swinepox viruses and expression of the classical swine fever virus E2 protein.
Hahn J; Park SH; Song JY; An SH; Ahn BY
J Virol Methods; 2001 Apr; 93(1-2):49-56. PubMed ID: 11311343
[TBL] [Abstract][Full Text] [Related]
13. Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.
Xu J; Huang D; Liu S; Lin H; Zhu H; Liu B; Lu C
Vaccine; 2012 Apr; 30(20):3119-25. PubMed ID: 22391400
[TBL] [Abstract][Full Text] [Related]
14. Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants.
Winslow BJ; Kalabat DY; Brown SM; Cochran MD; Collisson EW
Vet Microbiol; 2005 Nov; 111(1-2):1-13. PubMed ID: 16181751
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a novel recombinant vesicular stomatitis virus with triple mutations in its matrix protein as a vaccine for pigs.
Fang X; Qi B; Ma Y; Zhou X; Zhang S; Sun T
Vaccine; 2015 Nov; 33(46):6268-76. PubMed ID: 26431989
[TBL] [Abstract][Full Text] [Related]
16. Deletion mutants of Schmallenberg virus are avirulent and protect from virus challenge.
Kraatz F; Wernike K; Hechinger S; König P; Granzow H; Reimann I; Beer M
J Virol; 2015 Feb; 89(3):1825-37. PubMed ID: 25410877
[TBL] [Abstract][Full Text] [Related]
17. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.
Li J; Yu T; Wang X; Zhou J; Gao R; Zhang F; Gao X; Gao S; Liu X
Virol J; 2015 Jul; 12():113. PubMed ID: 26220290
[TBL] [Abstract][Full Text] [Related]
19. A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein.
Lin HX; Huang DY; Wang Y; Lu CP; Fan HJ
Vaccine; 2011 Sep; 29(40):7027-34. PubMed ID: 21807055
[TBL] [Abstract][Full Text] [Related]
20. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge.
Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF
Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
